Health AI Central
Share:
Peer-Reviewed Publication
J Med Internet Res2023;25e46781.July 10, 2023Randomized Controlled Trial

Effects of an Artificial Intelligence Platform for Behavioral Interventions on Depression and Anxiety Symptoms: Randomized Clinical Trial.

Shiri Sadeh-Sharvit1,2, T Del Camp3, Sarah E Horton3, Jacob D Hefner3, Jennifer M Berry3, Eyal Grossman1, Steven D Hollon4
1Eleos Health, Waltham, MA, United States.
2Palo Alto University, Palo Alto, CA, United States.
3Ozark Center, Freeman Health System, Joplin, MO, United States.
4Vanderbilt University, Nashville, TN, United States.
PubMed PMC DOI PDF

Abstract

BACKGROUND: The need for scalable delivery of mental health care services that are efficient and effective is now a major public health priority. Artificial intelligence (AI) tools have the potential to improve behavioral health care services by helping clinicians collect objective data on patients' progress, streamline their workflow, and automate administrative tasks. OBJECTIVE: The aim of this…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.